Methadone Hydrochloride Sugar Free Taw Pharma (Ireland) (Methadone Hydrochloride)

Methadone Hydrochloride is used within the opioid dependence and pain management pathways.

• Opioid dependence: reduces withdrawal symptoms and cravings, facilitating maintenance therapy.
• Chronic pain: provides analgesia for moderate to severe persistent pain when other opioids are unsuitable.
• Opioid detoxification: assists in controlled tapering of opioid use during supervised detox programs.

• Methadone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system. By binding to these receptors, it mimics the effects of endogenous opioids, diminishing the perception of pain and suppressing the neurochemical drive that underlies opioid withdrawal and craving. Its long half‑life provides stable plasma concentrations, supporting maintenance therapy and reducing the need for frequent dosing.

Methadone Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Constipation: reduced bowel motility.
• Dizziness: sensation of light‑headedness.
• Sweating: increased perspiration, especially at night.
• Drowsiness: feeling unusually sleepy.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be life‑threatening.
• QT interval prolongation: cardiac rhythm disturbance that may lead to arrhythmia.
• Severe hypotension: marked drop in blood pressure.
• Seizures: uncontrolled electrical activity in the brain.
• Allergic reactions: rash, itching, or anaphylaxis.
• Adrenal insufficiency: inadequate cortisol production.

When prescribing or dispensing Methadone Hydrochloride, several safety considerations are essential.

• Cardiac assessment: evaluate QT interval and correct electrolyte abnormalities before initiation.
• Respiratory monitoring: observe for signs of respiratory depression, especially during dose changes.
• Discontinuation: avoid abrupt cessation to prevent precipitated withdrawal.
• Hepatic impairment: adjust dosing and monitor liver function tests.
• Pregnancy: weigh benefits against potential fetal risks; use only if clearly needed.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone Hydrochloride interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates): increased risk of respiratory depression.
• QT‑prolonging agents (e.g., certain antiarrhythmics): heightened potential for cardiac arrhythmias.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise methadone plasma levels and toxicity.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower methadone concentrations, reducing efficacy.
• Monoamine oxidase inhibitors: risk of serotonin syndrome when combined with serotonergic agents.
• Anticholinergic drugs: can exacerbate constipation.
• Certain antidepressants (e.g., SSRIs): may modestly increase methadone levels.
• Alcohol: additive CNS depression, requiring careful monitoring.